Is Corvus Pharmaceuticals (CRVS) Now Attractive After Recent Share Price Volatility?
- If you are wondering whether Corvus Pharmaceuticals’ recent share price puts it at a bargain or a stretched level, you are not alone. This article is here to unpack what that current price might mean for value focused investors.
- The stock has been volatile, with a 7 day return of an 11.7% decline and a 30 day return of a 22.8% decline, set against a year to date return of 115.8% and a 1 year return of 271.6%, plus an increase of more than 7x over 3 years and 381.6% over 5 years.
- Recent trading interest has been shaped by ongoing attention on Corvus Pharmaceuticals’ clinical pipeline and its position within the US biotechnology space. Coverage has focused on how news around trial progress, regulatory milestones, and funding conditions…
Source link
